Frequent coauthors
- FUHRMANN ULRIKE 22
- KOCH MARKUS 11
- KAUFMANN REICHE ULRIKE 11
- MOELLER CARSTEN 11
- MICHELS MARTIN 11
- SCHMIDT ANJA 11
- SACHER FRANK 11
- VAKALOPOULOS ALEXANDROS 11
- ZOLLNER THOMAS 11
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.